Advisors Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Buy |
4,962
+3
| +0.1% | +$131 | ﹤0.01% | 1109 |
|
|
2025
Q1 | $136K | Buy |
4,959
+2,230
| +82% | +$61K | ﹤0.01% | 1151 |
|
|
2024
Q4 | $110K | Buy |
+2,729
| New | +$110K | ﹤0.01% | 1209 |
|
|
2024
Q1 | – | Sell |
-6,893
| Closed | -$175K | – | 1422 |
|
|
2023
Q4 | $175K | Sell |
6,893
-155
| -2% | -$3.95K | ﹤0.01% | 1129 |
|
|
2023
Q3 | $98K | Sell |
7,048
-78
| -1% | -$1.08K | ﹤0.01% | 1194 |
|
|
2023
Q2 | $164K | Sell |
7,126
-550
| -7% | -$12.6K | ﹤0.01% | 1149 |
|
|
2023
Q1 | $227K | Buy |
7,676
+5,349
| +230% | +$158K | ﹤0.01% | 1090 |
|
|
2022
Q4 | $58.1K | Buy |
+2,327
| New | +$58.1K | ﹤0.01% | 1325 |
|